Back to Network
4
Shared Docs
4
Same-Page
4 / 4
Mentions
Document Mentions (4 shared documents)
2 mentions1 same-page
Page ?Same page
ig Center for Cancer Genetics and 'Therapeutics at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine. Dr. Vogelstein was studying resistance to a colon cancer inhibitor called panitumumab. Enlisting Dr. Nenvak's help. Vogelstein and the PED designed a mathematical
f Ile. Bert Vogelstein, the lYinzetor of the Ludwig Center for Cancer Genetics and 'Therapeutics at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine. Dr. Vogelstein was studying resistance to a colon cancer inhibitor called panitumumab. Enlisting Dr. Nenvak's help. Vogelstein and the PED designed
2 mentions1 same-page
Page ?Same page
ig Center for Cancer Genetics and 'Therapeutics at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine. Dr. Vogelstein was studying resistance to a colon cancer inhibitor called panitumumab. Enlisting Dr. Nenvak's help. Vogelstein and the PED designed a mathematical
f Ile. Bert Vogelstein, the lYinzetor of the Ludwig Center for Cancer Genetics and 'Therapeutics at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine. Dr. Vogelstein was studying resistance to a colon cancer inhibitor called panitumumab. Enlisting Dr. Nenvak's help. Vogelstein and the PED designed
2 mentions1 same-page
Page ?Same page
ig Center for Cancer Genetics and Therapeutics at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine. Dr. Vogelstein was studying resistance to a colon cancer inhibitor called panitumumab. Enlisting Dr. Nowak's help, EFTA00583237 Vogelstein and the PED designed a
n of Dr. Bert Vogelstein, the Director of the Ludwig Center for Cancer Genetics and Therapeutics at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine. Dr. Vogelstein was studying resistance to a colon cancer inhibitor called panitumumab. Enlisting Dr. Nowak's help, EFTA00583237 Vogelstein and t
Sponsored
2 mentions1 same-page
Page ?Same page
wig Ccntcr for Cancer Genetics and Therapeutics at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine. Dr. Vogelstein was studying resistance to a colon cancer inhibitor called panitumumab. Enlisting Dr. Nowak's help. Vogelstein and the PED designed a mathematical m
on of Dr. Ben Vogelstein. the Director of the Ludwig Ccntcr for Cancer Genetics and Therapeutics at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine. Dr. Vogelstein was studying resistance to a colon cancer inhibitor called panitumumab. Enlisting Dr. Nowak's help. Vogelstein and the PED designed
Sponsored
Mutual Connections (16)
Entities connected to both Vogelstein and Johns Hopkins University School of Medicine
Martin Nowak
PERSON5 w/ Vogelstein·4 w/ Johns
Jeffrey Epstein
PERSON4 w/ Vogelstein·5 w/ Johns
the Program for Evolutionary Dynamics
ORGANIZATION4 w/ Vogelstein·4 w/ Johns
The Final Frontier
ORGANIZATION4 w/ Vogelstein·4 w/ Johns
the National Institute of Cancer
ORGANIZATION4 w/ Vogelstein·4 w/ Johns
Massachusetts General
ORGANIZATION3 w/ Vogelstein·3 w/ Johns
BV
Bert Vogelstein
PERSON3 w/ Vogelstein·3 w/ Johns
Johns Hopkins
ORGANIZATION2 w/ Vogelstein·3 w/ Johns
the Journal of Oncology
ORGANIZATION2 w/ Vogelstein·2 w/ Johns
Journal of Oncology
ORGANIZATION2 w/ Vogelstein·2 w/ Johns
a Biology and Mathematics
ORGANIZATION2 w/ Vogelstein·2 w/ Johns
Johns I Iopkins
ORGANIZATION2 w/ Vogelstein·2 w/ Johns
trials pandit&
ORGANIZATION2 w/ Vogelstein·2 w/ Johns
ET
EGER TX
PERSON2 w/ Vogelstein·2 w/ Johns
TG
the lYinzetor of the Ludwig Center for Cancer Genetics
PERSON2 w/ Vogelstein·2 w/ Johns
NE
Nenvak
PERSON2 w/ Vogelstein·2 w/ Johns